§ 13F · FUND PROFILE
Bain Capital Life Sciences Investors, LLC.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · $1506.7T (13F)Positions · 21Turnover · — · Q4Filed · Feb 17, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
No new positions
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q4 2025
FILED FEB 17, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q4 |
|---|---|---|---|---|---|---|
| 1 | HTFL | HEARTFLOW INC | 12.45M | $362.9T | 27.8% | ±0% |
| 2 | NAMS | NEWAMSTERDAM PHARMA COMPANY | 7.31M | $256.3T | 19.6% | −32% |
| 3 | OLMA | OLEMA PHARMACEUTICALS INC | 8.51M | $212.7T | 16.3% | +24% |
| 4 | SVRA | SAVARA INC | 17.60M | $106.1T | 8.1% | ±0% |
| 5 | PHVS | PHARVARIS N V | 2.80M | $77.8T | 6.0% | −12% |
| 6 | SLDB | SOLID BIOSCIENCES INC | 7.91M | $44.6T | 3.4% | ±0% |
| 7 | UPB | UPSTREAM BIO INC | 1.33M | $36.1T | 2.8% | −46% |
| 8 | XFOR | X4 PHARMACEUTICALS INC | 7.97M | $31.9T | 2.4% | +227% |
| 9 | DNTH | DIANTHUS THERAPEUTICS INC | 744K | $30.6T | 2.3% | −43% |
| 10 | KYTX | KYVERNA THERAPEUTICS INC | 3.11M | $29.2T | 2.2% | −8% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE BAIN SIGNAL
AC read
Bain Capital Life Sciences Investors, LLC is a Other fund managing $1506676.3 trillion in assets. The fund runs a focused portfolio of just 21 positions.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
2 FILINGS
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q3 2025
Steady book
+0 buys · −0 exits · 0 changed